A biotin-guided fluorescent-peptide drug delivery system for cancer treatment

Chem Commun (Camb). 2014 Jul 21;50(57):7690-3. doi: 10.1039/c4cc02878c.

Abstract

Herein, we present a fluorescent-peptide drug delivery system composed of biotin-naphthalimide-HJ inhibitor peptide2, prodrug 1. Treatment of 1 to biotin receptor-positive HepG2 cells, which are resistant to high concentrations of the HJ inhibitor peptide2, decreased cell viability and increased intracellular fluorescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • Biotin / administration & dosage*
  • Biotin / chemistry
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Drug Delivery Systems / methods*
  • Fluorescent Dyes / administration & dosage*
  • Fluorescent Dyes / chemistry
  • Hep G2 Cells
  • Humans
  • Peptides / administration & dosage*
  • Peptides / chemistry

Substances

  • Antineoplastic Agents
  • Fluorescent Dyes
  • Peptides
  • Biotin